02.11.2021 11:33:22
|
IDEXX Laboratories Inc Q3 Profit Rises, Beats estimates
(RTTNews) - IDEXX Laboratories Inc (IDXX) released earnings for its third quarter that rose from the same period last year.
The company's earnings came in at $175.24 million, or $2.03 per share. This compares with $146.22 million, or $1.69 per share, in last year's third quarter.
Analysts had expected the company to earn $1.91 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 12.3% to $810.42 million from $721.79 million last year.
IDEXX Laboratories Inc earnings at a glance:
-Earnings (Q3): $175.24 Mln. vs. $146.22 Mln. last year. -EPS (Q3): $2.03 vs. $1.69 last year. -Analysts Estimate: $1.91 -Revenue (Q3): $810.42 Mln vs. $721.79 Mln last year.
-Guidance: Full year EPS guidance: $8.30 - $8.38 Full year revenue guidance: $3,185 - $3,200 Mln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
03.02.25 |
Schwacher Wochentag in New York: NASDAQ Composite beendet den Handel im Minus (finanzen.at) | |
03.02.25 |
Verluste in New York: S&P 500 verbucht zum Handelsende Verluste (finanzen.at) | |
03.02.25 |
Schwacher Handel in New York: NASDAQ 100 zum Ende des Montagshandels schwächer (finanzen.at) | |
03.02.25 |
Verluste in New York: NASDAQ Composite nachmittags in Rot (finanzen.at) | |
03.02.25 |
Schwacher Handel in New York: NASDAQ 100 am Montagnachmittag schwächer (finanzen.at) | |
03.02.25 |
Handel in New York: S&P 500 legt den Rückwärtsgang ein (finanzen.at) | |
03.02.25 |
Verluste in New York: S&P 500 präsentiert sich mittags schwächer (finanzen.at) | |
03.02.25 |
Zurückhaltung in New York: NASDAQ Composite mittags in Rot (finanzen.at) |
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 444,20 | -2,74% |